Evidence map›Paper›PMID 22018469›Full record

ArticleImmunity2011

Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine.

Kanako L Lewis, Michele L Caton, Milena Bogunovic, Melanie Greter, Lucja T Grajkowska, Dennis Ng, Apostolos Klinakis, Israel F Charo, Steffen Jung, Jennifer L Gommerman and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 322 papers.

0numbers the graph read from it
0cells of the map it votes in
322citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

322 citing papers in PubMed, 513 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Targeted lungScience advances · 2026
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

262 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Kanako L LewisDepartment of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA.
Michele L Caton
Milena Bogunovic
Melanie Greter
Lucja T Grajkowska
Dennis Ng
Apostolos Klinakis
Israel F Charo
Steffen Jung
Jennifer L Gommerman
Ivaylo I Ivanov
Kang Liu
Miriam Merad
Boris Reizis
Columbia University Irving Medical Center · USIcahn School of Medicine at Mount Sinai · USUniversity of Toronto · CAAcademy of Athens · GRGladstone Institutes · USWeizmann Institute of Science · IL

Funding

Molecular Control of Plasmacytoid Dendritic Cell Development and FunctionR37AI072571 · NIAID · UNIVERSITY OF CHICAGO · PI Boris Reizis · 2018 to 2026
$5.3M
Molecular Control of Plasmacytoid Dendritic Cell Development and FunctionR01AI072571 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI REIZIS, BORIS · 2008 to 2017
$4.1M
TRAINING PROGRAM IN MICROBIOLOGY FOR INFECTIOUS DISEASEST32AI007161 · NIAID · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI FIDOCK, DAVID A · 1985 to 2008
$1.9M
Stem Cells and Cell Lineage SpecificationT32HD055165 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HOBERT, OLIVER · 2007 to 2011
$1.3M
Regulation of Mucosal Th17 Cell Responses by Intestinal BacteriaR00DK085329 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IVANOV, IVAYLO IVANOV · 2011 to 2013
$721k
Dendritic Cell-Specific Gene Targeting and ExpressionR21AI067804 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REIZIS, BORIS · 2006 to 2007
$436k
Regulation of Mucosal Th17 Cell Responses by Intestinal BacteriaK99DK085329 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI IVANOV, IVAYLO IVANOV · 2010 to 2010
$90k
CIHR MOP 67157NIAID NIH HHS AI007161NIAID NIH HHS AI072571NIAID NIH HHS R01 AI072571NIAID NIH HHS R21 AI067804NIAID NIH HHS R37 AI072571NIAID NIH HHS T32 AI007161NICHD NIH HHS HD055165NICHD NIH HHS T32 HD055165NIDDK NIH HHS DK085329NIDDK NIH HHS K99 DK085329NIDDK NIH HHS R00 DK085329
6 · The paper itself

Abstract

Dendritic cells (DCs) in tissues and lymphoid organs comprise distinct functional subsets that differentiate in situ from circulating progenitors. Tissue-specific signals that regulate DC subset differentiation are poorly understood. We report that DC-specific deletion of the Notch2 receptor caused a reduction of DC populations in the spleen. Within the splenic CD11b(+) DC subset, Notch signaling blockade ablated a distinct population marked by high expression of the adhesion molecule Esam. The Notch-dependent Esam(hi) DC subset required lymphotoxin beta receptor signaling, proliferated in situ, and facilitated CD4(+) T cell priming. The Notch-independent Esam(lo) DCs expressed monocyte-related genes and showed superior cytokine responses. In addition, Notch2 deletion led to the loss of CD11b(+)CD103(+) DCs in the intestinal lamina propria and to a corresponding decrease of IL-17-producing CD4(+) T cells in the intestine. Thus, Notch2 is a common differentiation signal for T cell-priming CD11b(+) DC subsets in the spleen and intestine.

Indexed as

Cell DifferentiationSignal TransductionAnimalsCells, CulturedDendritic CellsFemalefms-Like Tyrosine Kinase 3Gene Expression ProfilingGene Expression Regulation, DevelopmentalImmunoglobulin J Recombination Signal Sequence-Binding ProteinIntestinal MucosaIntestinesMaleMiceMice, Inbred C57BLMice, TransgenicFlt3 protein, mousefms-Like Tyrosine Kinase 3Immunoglobulin J Recombination Signal Sequence-Binding ProteinRbpj protein, mouseReceptor, Notch2

Identifiers

PMID22018469
PMCPMC3225703
OpenAlexW2010562798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.